Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma
Background CD38 has been established as an important therapeutic target for multiple
myeloma (MM), for which two CD38 antibodies are currently approved—daratumumab and …
myeloma (MM), for which two CD38 antibodies are currently approved—daratumumab and …
[HTML][HTML] Therapy in the Course of Kidney Graft Rejection—Implications for the Cardiovascular System—A Systematic Review
J Mizera, J Pilch, U Giordano, M Krajewska, M Banasik - Life, 2023 - mdpi.com
Kidney graft failure is not a homogenous disease and the Banff classification distinguishes
several types of graft rejection. The maintenance of a transplant and the treatment of its …
several types of graft rejection. The maintenance of a transplant and the treatment of its …
Single-Cell Heterogeneity Restorative Chimeric Engineering Nanoparticles for Alleviating Antibody-Mediated Allograft Injury
J Lin, J Lv, X Yu, X Xue, S Yu, H Wang… - ACS Applied Materials …, 2023 - ACS Publications
Disturbance of single-cell transcriptional heterogeneity is an inevitable consequence of
persistent donor-specific antibody (DSA) production and allosensitization. However …
persistent donor-specific antibody (DSA) production and allosensitization. However …
[HTML][HTML] Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab—A Preliminary Study
C Arrivé, M Jacquet, E Gautier-Veyret, T Jouve… - Journal of Clinical …, 2023 - mdpi.com
Tocilizumab prevents clinical worsening of chronic antibody-mediated rejection (CAMR) of
kidney transplant recipients. Optimization of this treatment is necessary. We identified the …
kidney transplant recipients. Optimization of this treatment is necessary. We identified the …
Graft Protective and Intercellular Immunomodulatory Effects by Adoptive Transfer of an Agonistic Anti-BTLA mAb (3C10) Induced CD4+ CD25+ Regulatory T Cells in …
H Masaoka, Y Yamamoto, M Uchiyama, K Iguchi… - Transplantation …, 2024 - Elsevier
Background We demonstrated that an agonistic anti-B and T lymphocyte attenuator antibody
(3C10) prolonged cardiac survival by inducing regulatory T cells (Treg). However, the …
(3C10) prolonged cardiac survival by inducing regulatory T cells (Treg). However, the …
贵州省首例跨血型亲属活体肾移植围手术期的护理
许艳艳， 牛玉林， 丁蓓 - 实用临床医药杂志 - jcmp.yzu.edu.cn
ABO 血型不相符活体肾移植是目前扩大活体供体库的常规方法. 尽管肾移植术后排斥反应,
感染等并发症相关报道较多, 但随着免疫抑制剂方案和脱敏治疗的发展, 肾脏移植物和患者的 …
感染等并发症相关报道较多, 但随着免疫抑制剂方案和脱敏治疗的发展, 肾脏移植物和患者的 …
TDM of belatacept and other biologicals in transplantation.
S Bergan, NT Vethe - Authorea Preprints, 2024 - advance.sagepub.com
In solid organ transplantation biologicals like recombinant therapeutic proteins, monoclonal
antibodies, fusion proteins and conjugates are increasingly used for immunosuppression …
antibodies, fusion proteins and conjugates are increasingly used for immunosuppression …
Landscape of the Immune Infiltration and Identification of Molecular Diagnostic Markers Associated With Immune Cells in Patients With Kidney Transplantation
Z Xu, X Sun, X Ma, B Tao, J Wu, Y He, Y Zhao, H Mao… - 2024 - researchsquare.com
Rejection seriously affects the success of kidney transplantation. However, the molecular
mechanism of the occurrence of rejection remains unclear. Firstly, GSE21374 and …
mechanism of the occurrence of rejection remains unclear. Firstly, GSE21374 and …
Perioperative nursing for kidney transplantation from a related living-donor with blood-type mismatched: the first case in Guizhou Province
XU Yanyan, NIU Yulin, D Bei - Journal of Clinical Medicine in Practice - jcmp.yzu.edu.cn
Living kidney transplantation with ABO blood type mismatch is currently a routine method for
expanding the living donor unit. Although there have been many reports of complications …
expanding the living donor unit. Although there have been many reports of complications …
[PDF][PDF] Is Lack of Consensus on the Management of Chronic Active Antibody-Mediated Rejection Harming Renal Transplant Recipients?
L Rostaing - emjreviews.com
Given this lack of consensus, what does the clinical landscape look like for patients with
CABMR? By conducting an online survey with European nephrologists, transplant …
CABMR? By conducting an online survey with European nephrologists, transplant …